Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
GERNGeron(GERN) ZACKS·2024-08-08 21:17

Geron (GERN) came out with a quarterly loss of 0.10pershareversustheZacksConsensusEstimateofalossof0.10 per share versus the Zacks Consensus Estimate of a loss of 0.11. This compares to loss of 0.09pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof9.090.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.09%. A quarter ago, it was expected that this drugmaker would post a loss of 0.10 per share when it actually produced a loss of $0.09, delivering a surprise of 10%.Over the last four quarters, the company has surpassed consensus ...